August 20, 2014 | BioView, a company specializing in automating laboratory tests, announced that it will expand its cooperation with medical equipment and diagnostics company Abbot Laboratories. BioView made the announcement today to the Tel Aviv Stock Exchange that it signed an agreement with Abbot for development purposes. According to the current agreement, Abbot will develop signs using Fish technology to identify and excess or lack of a certain genes in a cell with the goal of determining whether a certain gene is responsible for the development of diseases. Abbot is currently developing the sign while BioView is developing the identification software. BioView was founded in 2000 and is headquartered in Rehovot, Israel
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments